These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 31754397

  • 61. HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p.
    Chao H, Zhang M, Hou H, Zhang Z, Li N.
    Life Sci; 2020 Feb 15; 243():117296. PubMed ID: 31935390
    [Abstract] [Full Text] [Related]

  • 62. Traditional Chinese medicine Jianpi Bushen therapy suppresses the onset of pre-metastatic niche in a murine model of spontaneous lung metastasis.
    Zhu X, Zhou Y, Xu Q, Wu J.
    Biomed Pharmacother; 2017 Feb 15; 86():434-440. PubMed ID: 28012398
    [Abstract] [Full Text] [Related]

  • 63. miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.
    Wang J, Liu L, Sun Y, Xue Y, Qu J, Pan S, Li H, Qu H, Wang J, Zhang J.
    Biomed Pharmacother; 2018 May 15; 101():406-413. PubMed ID: 29501762
    [Abstract] [Full Text] [Related]

  • 64. Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.
    Hsu KW, Fang WL, Huang KH, Huang TT, Lee HC, Hsieh RH, Chi CW, Yeh TS.
    Oncotarget; 2016 Jun 21; 7(25):38036-38051. PubMed ID: 27191259
    [Abstract] [Full Text] [Related]

  • 65. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y, Chen Z, Li MJ, Guo HY, Jing NC.
    Biomed Pharmacother; 2017 Jan 21; 85():264-271. PubMed ID: 27887846
    [Abstract] [Full Text] [Related]

  • 66. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 67. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X, Chen S, Xiu YL, Sun KX, Zong ZH, Zhao Y.
    Mol Cancer; 2015 Feb 04; 14(1):31. PubMed ID: 25649143
    [Abstract] [Full Text] [Related]

  • 68. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF, Shen DF, Yang XF, Zhao S, Liu YP, Sun HZ, Su RJ, Luo JS, Zheng HC.
    Oncotarget; 2015 Aug 14; 6(23):19552-79. PubMed ID: 25980581
    [Abstract] [Full Text] [Related]

  • 69. Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients.
    Liu B, Liu Z, Wang Y, Lian X, Han Z, Cheng X, Zhu Y, Liu R, Zhao Y, Gao Y.
    Mol Med; 2021 Sep 23; 27(1):117. PubMed ID: 34556022
    [Abstract] [Full Text] [Related]

  • 70. Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts.
    Appledorn DM, Dao KH, O'Reilly S, Maher VM, McCormick JJ.
    BMC Cancer; 2010 Jan 12; 10():13. PubMed ID: 20067638
    [Abstract] [Full Text] [Related]

  • 71. miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.
    Chen Q, Chen X, Zhang M, Fan Q, Luo S, Cao X.
    Dig Dis Sci; 2011 Jul 12; 56(7):2009-16. PubMed ID: 21221794
    [Abstract] [Full Text] [Related]

  • 72. Novel rapid immunohistochemistry using an alternating current electric field identifies Rac and Cdc42 activation in human colon cancer FFPE tissues.
    Tsuda M, Horio R, Wang L, Takenami T, Moriya J, Suzuka J, Sugino H, Tanei Z, Tanino M, Tanaka S.
    Sci Rep; 2022 Feb 02; 12(1):1733. PubMed ID: 35110666
    [Abstract] [Full Text] [Related]

  • 73. HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42.
    Johnson E, Seachrist DD, DeLeon-Rodriguez CM, Lozada KL, Miedler J, Abdul-Karim FW, Keri RA.
    J Biol Chem; 2010 Sep 17; 285(38):29491-501. PubMed ID: 20595387
    [Abstract] [Full Text] [Related]

  • 74. lncRNA DSCR8 mediates miR-137/Cdc42 to regulate gastric cancer cell proliferation, invasion, and cell cycle as a competitive endogenous RNA.
    Chen Z, Xu C, Pan X, Cheng G, Liu M, Li J, Mei Y.
    Mol Ther Oncolytics; 2021 Sep 24; 22():468-482. PubMed ID: 34553033
    [Abstract] [Full Text] [Related]

  • 75. miR-124-regulated RhoG reduces neuronal process complexity via ELMO/Dock180/Rac1 and Cdc42 signalling.
    Franke K, Otto W, Johannes S, Baumgart J, Nitsch R, Schumacher S.
    EMBO J; 2012 Jun 29; 31(13):2908-21. PubMed ID: 22588079
    [Abstract] [Full Text] [Related]

  • 76. TRIP13 regulates progression of gastric cancer through stabilising the expression of DDX21.
    Zhang G, Yang R, Wang B, Yan Q, Zhao P, Zhang J, Su W, Yang L, Cui H.
    Cell Death Dis; 2024 Aug 26; 15(8):622. PubMed ID: 39187490
    [Abstract] [Full Text] [Related]

  • 77. GINS4 suppresses ferroptosis by antagonizing p53 acetylation with Snail.
    Chen L, Cai Q, Yang R, Wang H, Ling H, Li T, Liu N, Wang Z, Sun J, Tao T, Shi Y, Cao Y, Wang X, Xiao D, Liu S, Tao Y.
    Proc Natl Acad Sci U S A; 2023 Apr 11; 120(15):e2219585120. PubMed ID: 37018198
    [Abstract] [Full Text] [Related]

  • 78. MICAL-L2 potentiates Cdc42-dependent EGFR stability and promotes gastric cancer cell migration.
    Min P, Zhao S, Liu L, Zhang Y, Ma Y, Zhao X, Wang Y, Song Y, Zhu C, Jiang H, Gu L, Du J.
    J Cell Mol Med; 2019 Jun 11; 23(6):4475-4488. PubMed ID: 31034158
    [Abstract] [Full Text] [Related]

  • 79. RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway.
    Wang S, Lu A, Chen X, Wei L, Ding J.
    PLoS One; 2014 Jun 11; 9(11):e113891. PubMed ID: 25427001
    [Abstract] [Full Text] [Related]

  • 80. Cdc42 Mediates Cancer Cell Chemotaxis in Perineural Invasion.
    Chernichenko N, Omelchenko T, Deborde S, Bakst RL, He S, Chen CH, Gusain L, Vakiani E, Katabi N, Hall A, Wong RJ.
    Mol Cancer Res; 2020 Jun 11; 18(6):913-925. PubMed ID: 32086369
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.